Trial Profile
Pharamocokinetics study of recombinant thrombomodulin in pediatric patients with hematological disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Apr 2016
Price :
$35
*
At a glance
- Drugs Thrombomodulin alfa (Primary)
- Indications Disseminated intravascular coagulation; Embolism and thrombosis
- Focus Pharmacokinetics
- 12 Mar 2016 Population pharmacokinetic analysis (n=8) presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 12 Mar 2016 Results (n=8) presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 20 Nov 2015 Status changed from not yet recruiting to completed, according to University Hospital Medical Information Network - Japan record.